Aspen Pharmacare Holdings Stock Short Ratio
Aspen Pharmacare Holdings fundamentals help investors to digest information that contributes to Aspen Pharmacare's financial success or failures. It also enables traders to predict the movement of Aspen Pink Sheet. The fundamental analysis module provides a way to measure Aspen Pharmacare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aspen Pharmacare pink sheet.
Aspen |
Aspen Pharmacare Holdings Company Short Ratio Analysis
Aspen Pharmacare's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Aspen Pharmacare Holdings has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
All Next | Launch Module |
Aspen Fundamentals
Return On Equity | 0.095 | |||
Return On Asset | 0.0499 | |||
Profit Margin | 0.17 % | |||
Operating Margin | 0.23 % | |||
Current Valuation | 4.58 B | |||
Shares Outstanding | 444.95 M | |||
Shares Owned By Insiders | 19.32 % | |||
Shares Owned By Institutions | 60.77 % | |||
Price To Earning | 11.83 X | |||
Price To Book | 0.98 X | |||
Price To Sales | 0.10 X | |||
Revenue | 38.61 B | |||
Gross Profit | 18.29 B | |||
EBITDA | 10.61 B | |||
Net Income | 6.49 B | |||
Cash And Equivalents | 7.88 B | |||
Cash Per Share | 17.25 X | |||
Total Debt | 105 M | |||
Debt To Equity | 0.38 % | |||
Current Ratio | 1.96 X | |||
Book Value Per Share | 159.44 X | |||
Cash Flow From Operations | 5.37 B | |||
Earnings Per Share | 0.80 X | |||
Number Of Employees | 8.58 K | |||
Beta | 0.62 | |||
Market Capitalization | 3.92 B | |||
Total Asset | 111.38 B | |||
Retained Earnings | 28.4 B | |||
Working Capital | 16.1 B | |||
Current Asset | 37.2 B | |||
Current Liabilities | 21.1 B | |||
Z Score | 22.2 | |||
Annual Yield | 0.02 % | |||
Net Asset | 111.38 B | |||
Last Dividend Paid | 3.26 |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Aspen Pink Sheet
If you are still planning to invest in Aspen Pharmacare Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aspen Pharmacare's history and understand the potential risks before investing.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |